欢迎来到天天文库
浏览记录
ID:43242784
大小:7.58 MB
页数:39页
时间:2019-10-07
《缺血性和非缺血性心肌病的外科治疗》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库。
1、Non-transplantsurgicaltreatmentforischemicandnon-ischemiccardiomyopathyHayamaHeartCenterTadashiIsomura,JyojiHoshino,YasuhisaFukada,ShintaroKatahiraOperationforDCM(Dilatedcardiomyopathy)Surgicaltreatmentforischemicornon-ischemicdilatedcardiomyopathy(DCM)isachallengingtreatment.Leftventricularre
2、storation(LVR)orvalvesurgerywithotheraggressivetreatmentwasconductedandevaluated.Dyskinesis=LVaneurysmAkinesis=IschemicDCMDor.V;CurrentOpinioninCardiology1997,12:5341991.1235yM1999.643yMICM:LVRemodelingDCM,noMRPreopLVGNon-ischemicDCMCAG,LVG,BiopsyCardiacecho:ColorkinesisScintigramCine-MRISpec
3、kletrackingimageRadial,Circumferential,LongitudinalExaminationbeforeoperationRadialStrainSeptalLateralPosteriorNormalSeptalLateralPosteriorNormalHeartSpeckletrackingimage:CircumferentialstrainDCMNormalIschemic/Non-ischemic176/290Age57±9range29~83Male/Female379/87NYHAclassⅢ/Ⅳ257/209Elective/Eme
4、rgent380/86DCM(n=466)1997~2008.7OperativeproceduresforDCMLeftVentricularRestoration(LVR)EVCPP(Dor),SAVE,PLV(Batista)MitralValveSurgeryCABGCRT-D,Cryoablation………①EVCPP(Dor),②SAVE、③PLV(Batista)LVRIndicationforSAVEIndicationforPLVSAVE(SeptalanteriorVentricularExclusionwithlargepatch)EVCPP(Dor)98SA
5、VE(oroverlap)63(3)PLV(Batista)15CABG(n=143)2.7±1.3/patientMitral90(51%)MVR/MVP18/72Tricuspid29Cryoablation78(44%)IABP/LVAD27/3IschemicDCM(n=176)1997~2008.7SurgicalproceduresforNon-ischemicDCM-2006.5PLV(Batista)111(66%)-SAVE(orOverlap)57(3)-MVP/MVR84/74(94%)82/26(89%)TAP/TVR83/4(52%)78/5(68%)AV
6、R617Cryoablation6110PMplication32(19%)11(9%)CRT32(19%)21(17%)IABP/LVAD39/419/1WithLVR(n=168)WithoutLVR(n=122)IschemicDCM(n=176)Non-ischemicDCM(n=290)HospitaldeathElective6/150(4.0%)18/230(7.8%)Emergent8/26(31.0%)29/60(48.3%)LatefollowupNYHAclass1-2132148NYHAclass3-4920Latedeath20(CHF11,VT7,non
7、-cardiac2)75(CHF52,VT12,non-cardiac11)SurgicalresultsforDCM(N=466)PrognosisofCHFofStageCCirculation2007;115:1563-1570PrevalenceofCHFintheCommunity---AmmarKAetal.100.2234567Survivalrate0.40.60.81.0years0ABC1C2Circulation2007;115:1563-157
此文档下载收益归作者所有